About this trial
The primary objective is to compare Re-Q Pro-Longevity serum versus vehicle serum combined with Intense Pulsed Laser for the treatment of moderate to severe photodamage and crepiness on the dorsal forearms.
Eligibility criteria
Qualifiers
Female participants aged 50 to 80 years.
Fitzpatrick skin types I-IV.
Moderate to severe photodamage and crepiness on the arms, based on clinical evaluation, including fine wrinkling, coarse wrinkling, photodamage, and a global assessment as assessed with the 10-point Dermatologic Assessment Form and Photographic Scale
Willing and able to comply with all study requirements, including scheduled visits, treatment protocol, and follow-up assessments.
Disqualifiers
Patients with dark hair in the treatment area who are unwilling to shave the treated area prior to IPL treatments or who are unwilling to proceed knowing IPL will eliminate at least 50% of the hairs in the treatment area
A suntan in the treatment area or use of sunless tanner/spray-tan in the treatment areas 4 weeks prior to study treatment
Active infection, open wounds, or inflammatory dermatoses (e.g., eczema, psoriasis, dermatitis) in the treatment area.
Use of at-home energy-based devices intended for rejuvenation or fibroblastic/collagen stimulation on the treatment area within 30 days prior to treatment and during the study period.
Trial design
Treatments tested in this trial
- Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy
- Left Arm treated with vehicle serum and Intense Pulsed Light Therapy
Treatment groups
Sponsors and collaborators
Goldman, Butterwick, Fitzpatrick and Groff
Lead sponsor
Rapalogix
Collaborator